Price$7.30-0.35 (-4.57%)
01:30 PM07:00 PM
News · 26 weeks95+240%
2026-04-192026-10-11
Mix5190d
- Insider19(37%)
- SEC Filings15(29%)
- Other10(20%)
- Analyst3(6%)
- Earnings2(4%)
- Leadership2(4%)
Latest news
25 items- INSIDERSEC Form 4 filed by Butterfly Network Inc.4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERSEC Form 3 filed by Butterfly Network Inc.3 - Butterfly Network, Inc. (0001804176) (Issuer)
- PRThe Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network Announce Long-Term Alliance to Build New Model for Ultrasound EducationJoint investment will establish VCOM as a center of excellence for ultrasound education, in a first-of-its kind model combining 1:1 probe deployment and integrated education with longitudinal tracking from medical school through clinical practice in rural communities. The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network, Inc. (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced a long-term alliance and joint investment in establishing VCOM and its students as a center of excellence for ultrasound education and community care. The first-of-its-kind program combines one-probe-per-student deployment, integr
- ANALYSTCanaccord Genuity initiated coverage on Butterfly Network with a new price targetCanaccord Genuity initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $10.00
- INSIDERSEC Form 4 filed by Butterfly Network Inc.4 - Butterfly Network, Inc. (0001804176) (Issuer)
- PRButterfly Network to Report Third Quarter 2026 Financial Results on October 29, 2026Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on October 29 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly’s Investor Relations website at ir.butterflynetwork
- INSIDERSEC Form 4 filed by Butterfly Network Inc.4 - Butterfly Network, Inc. (0001804176) (Issuer)
- PRBridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer InterfaceBridge will leverage Butterfly’s programmable Ultrasound-on-Chip™ technology to pursue real-time brain imaging and interaction using sound, without surgery or implants. Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced a research and development agreement through Butterfly Embedded™. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006815892/en/ Bridge was founded with a
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- SECButterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Butterfly Network, Inc. (0001804176) (Filer)
- PRButterfly Network Appoints Mike Noonen to Board of DirectorsSeasoned Semiconductor Leader Brings Three Decades of Experience Scaling Chip Companies Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Mike Noonen to its Board of Directors, effective October 9, 2026. Mr. Noonen will serve on the Board's Compensation Committee and Technology Committee. With his appointment, the Board expands to seven directors. Mr. Noonen is a seasoned semiconductor executive with 30 years of experience leading technology businesses, resulting in two IPOs and multiple acquisitions. He most recently served as CEO of Swave Photonics, a
- PRMendaera’s Focalist™ System Now Compatible with Butterfly’s Ultrasound-on-Chip™ TechnologyLaunch of the Butterfly-compatible Focalist™ system advances software-defined imaging for robotic intervention, while marking the first Butterfly Embedded™ partner technology to reach the market. Mendaera, Inc., a healthcare technology company building robotics and intelligence for procedural medicine, and Butterfly Network, Inc. (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced that Mendaera’s Focalist™ system is now commercially available with Butterfly Network’s Ultrasound-on-Chip™ imaging technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001
- ANALYSTEvercore ISI initiated coverage on Butterfly Network with a new price targetEvercore ISI initiated coverage of Butterfly Network with a rating of Outperform and set a new price target of $15.00
- INSIDERPresident & CEO Devivo Joseph sold $59,867 worth of shares (5,980 units at $10.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 7,347,720 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- ANALYSTNeedham initiated coverage on Butterfly Network with a new price targetNeedham initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $10.00
- INSIDERChief Business Officer Cashman Steve sold $1,023,098 worth of shares (140,112 units at $7.30), decreasing direct ownership by 9% to 1,490,295 units (SEC Form 4) (tax liability)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERCAO and SVP, Finance Carlson Megan sold $100,797 worth of shares (13,804 units at $7.30), decreasing direct ownership by 3% to 412,085 units (SEC Form 4) to cover taxes4 - Butterfly Network, Inc. (0001804176) (Issuer)
- PRButterfly Network to Participate in Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound, cloud software and AI, today announced that it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 15, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting Officer, will attend and host one-on-one investor meetings. The Company will participate in a fireside chat at 10:00 AM ET on September 15th. A webcast of the fireside chat will be available in the Events & Presentations section of the Butterfly investo
- PRMerge Labs and Butterfly Network Partner to Advance Ultrasound-Based Brain-Computer InterfacesPartnership brings together frontier BCI innovation and leading semiconductor-based ultrasound to enable new, less-invasive ways to interface with the human brain. Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, and Merge Labs today announced a multi-year licensing agreement through Butterfly Embedded™. The agreement gives Merge access to Butterfly’s Poseidon Family of Ultrasound-on-Chip™ technology for the development of ultrasound-based brain-computer interfaces (BCI). Merge Labs was founded with the long-term mission of bridging biological and artificial intelligence to maximize human abili
- INSIDERPresident & CEO Devivo Joseph gifted 250,000 shares, decreasing direct ownership by 3% to 7,353,700 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
- INSIDERDirector Robbins Larry sold $20,622,493 worth of shares (2,297,733 units at $8.98) (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
BFLY FAQ
7 questionsWhat does Butterfly Network Inc. do?
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.Where does BFLY stock trade?
Butterfly Network Inc. (BFLY) is listed on NYSE.What sector and industry is BFLY in?
Butterfly Network Inc. operates in the Health Care sector, Medical Electronics industry.When did Butterfly Network Inc. go public?
Butterfly Network Inc. (BFLY) completed its IPO in 2020.What are analysts saying about BFLY?
Butterfly Network Inc. has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy with a $1000.00 price target on 2026-10-12.What companies are similar to BFLY?
Notable peers in the same industry include GEHC (GE HealthCare Technologies Inc.), PHG (Koninklijke Philips N.V. NY Registry Shares), HOLX (Hologic Inc.), MBAI (Check-Cap Ltd.), NNOX (NANO-X IMAGING LTD). Compare BFLY side-by-side with any of them on Quantisnow.How can I track BFLY on Quantisnow?
Quantisnow aggregates Butterfly Network Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BFLY to receive live email and push alerts on every new disclosure.